Oral polio vaccine type 3 and trivalent product licensed in the U.S.
On Mar. 27, 1962, the Sabin oral polio vaccine (OPV) type 3 MOPV was licensed in the U.S.,…
On Mar. 27, 1962, the Sabin oral polio vaccine (OPV) type 3 MOPV was licensed in the U.S.,…
In 1962, oral polio vaccine types 1 and 2, developed by Dr. Albert Sabin and grown in monkey…
In 1961, oral polio vaccine, developed by Dr. Albert Sabin, was licensed for use in the U.S. In…
In 1960, the U.S. Surgeon General, in response to substantial morbidity and mortality during the 1957-58 pandemic, recommends…
In 1959, the Salk Institute was initially envisioned by Jonas Salk, M.D., the developer of the polio vaccine,…
In 1958, mpox (MPVX) was first discovered when two nonfatal outbreaks of a pox-like disease were reported in…
In 1958, the U.S. Centers for Disease Control and Prevention (CDC) sent a team of EIS officers to…
In 1958, Hollister-Stier Laboratories became a subsidiary of Cutter Laboratories. Hollister-Stier Laboratories, located in Spokane, was founded by…
In Feb. 1957, a new influenza A (H2N2) virus emerged in East Asia, triggering a pandemic (‘Asian Flu’)….
In Feb. 1957, a new influenza A (H2N2) virus emerged in East Asia, triggering a pandemic (“Asian Flu”)….
On Jan. 27, 1956, Dr. Jonas Salk, developer of the Polio vaccine released in 1955, received a special…
On Aug. 17, 1955, the U.S. Food and Drug Administration (FDA) announced the hiring of 48 temporary investigators…
On Apr. 26, 1955, Officials first noticed an increase in reported polio cases in California. In April 1955…
On Apr. 12, 1955, the polio vaccine developed by Dr. Jonas Salk at the University of Pittsburgh was…
On Apr. 12, 1955, a convocation was held at the University of Michigan (UM), where Dr. Thomas Francis…
In April 1955, Cutter Laboratories, located in Berkeley, California and one of several companies licensed by the U.S….
From 1955 through early 1963, millions of people were accidentally exposed to simian virus 40 (SV40) as a…
In 1955, the Polio Vaccination Assistance Act was enacted by the U.S. Congress, the first federal involvement in…
On Apr. 28, 1955, The National Poliomyelitis Surveillance Program was established by the Surgeon General of the Public…
In 1955, Canada contributed to the safe cultivation of the poliovirus, using Medium 199, and an incubation process…
In 1955, the Division of Biologics Control (DBS) became an independent entity within the National Institutes of Health…
On Apr. 26, 1954, the largest controlled Polio vaccine field trial in the history of medicine got under…
On Mar. 22, 1954, Dr. Jonas Salk’s team began giving inoculations of a commercially prepared vaccine to some…
On Feb. 23, 1954, the first mass inoculation of the new Polio vaccine, developed by Dr. Jonas Salk…
In February 1954, first-, second- and third-grade students from five suburban schools were the first to be inoculated…
In 1954, John Franklin Enders and Thomas C. Peebles isolated measles virus from an 11-year-old boy, David Edmonston….
On Nov. 13, 1956, a scientific team led by John Enders at Harvard, known as “the Father of…
In 1954, Dr. Thomas Francis, Jr., University of Michigan, directed field trials of Salk vaccine sponsored by NFIP….
In 1954, Dr. Jonas Salk and associates develop a potentially safe injectable vaccine against polio given to nearly…
On May 16, 1953, Dr. Jonas Salk initiated the first community-based pilot trial of the Polio vaccine in…